WooGene B&G Company Description

WooGene B&G Co., Ltd. engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally.

It offers antibiotic, vaccine, nutrient, anti-inflammation, metabolic stimulant, and iron supplement products for swine, poultry, cattle, aquatic animals, companion animals, and raw materials, as well as operates vaccine research center.

The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001.

WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Hwaseong, South Korea.

WooGene B&G Co., Ltd

Country	South Korea
Founded	1977
Industry	Pharmaceutical Preparations
Employees	84
CEO	Seokjin Kang

Contact Details

Address: 230, Jeongmunsongsan-ro Hwaseong South Korea
Phone	82 3 1352 0185
Website	woogenebng.com

Stock Details

Ticker Symbol	018620
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2834

Key Executives

Name	Position
Seokjin Kang	Chief Executive Officer